Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy. [PDF]
Liu W, Moriarity BS, Webber BR.
europepmc +1 more source
Genetic engineering of gut commensals: heterologous protein expression in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> CECT8145. [PDF]
Arévalo-Lalanne A +5 more
europepmc +1 more source
Expanding genetic engineering capabilities in Vibrio natriegens with the Vnat Collection. [PDF]
Faber A +9 more
europepmc +1 more source
CRISPR.BOT an autonomous platform for streamlined genetic engineering and molecular biology applications. [PDF]
Erkek F +18 more
europepmc +1 more source
Genetic engineering for SIT application: a fruit fly-focused review. [PDF]
Davydova S, Yu D, Meccariello A.
europepmc +1 more source
Scarless Genetic Engineering of <i>Saccharomyces cerevisiae</i> for Enhanced Guanosine Monophosphate Production as a Natural Flavor Enhancer. [PDF]
Jung SC +6 more
europepmc +1 more source
Related searches:
A Genetic Engineering Approach to Genetic Algorithms
Evolutionary Computation, 2001We present an extension to the standard genetic algorithm (GA), which is based on concepts of genetic engineering. The motivation is to discover useful and harmful genetic materials and then execute an evolutionary process in such a way that the population becomes increasingly composed of useful genetic material and increasingly free of the harmful ...
John S. Gero, Vladimir A. Kazakov
openaire +3 more sources
D uring the next 25 years, world population is expected to increase by about 2.5 billion people, with most of this projected population growth expected to occur in developing countries. The food requirements in the developing world are expected to double by 2025.
C, Somerville, J, Briscoe
openaire +2 more sources
Genetically engineered vaccines
Current Allergy and Asthma Reports, 2005The application of recombinant DNA technology to allergen research has provided the sequence information and genetic material to produce new types of allergy vaccines. One general strategy has been to use the knowledge to produce synthetic peptides that represent selected T-cell or B-cell epitopes.
Wayne R, Thomas +2 more
openaire +2 more sources
Genetic engineering for haemophilia A
Expert Opinion on Biological Therapy, 2006At first sight, haemophilia A would appear to be an ideal candidate for treatment by gene therapy. There is a single gene defect; cells in different parts of the body, but especially the liver, produce Factor VIII, and only 5% of normal levels of Factor VIII are necessary to prevent the serious symptoms of bleeding.
Shu Uin, Gan, Oi Lian, Kon, Roy Y, Calne
openaire +2 more sources

